Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
IBOCompany Name
IMPACT BIOMEDICAL INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTIMPACT BIOMEDICAL INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IBO - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -10.34M | $ -38.47M | 0% |
| 3/31/2025 | $ 3.84M | $ -25.02M | -650.98% |
| 12/31/2024 | $ 4.26M | $ -24.71M | -580.14% |
| 9/30/2024 | $ 31.35M | $ 1.16M | 3.7% |
| 6/30/2024 | $ 23.37M | $ -4.25M | -18.17% |
| 3/31/2024 | $ 24.26M | $ -4.46M | -18.39% |
| 12/31/2023 | $ 25.22M | $ -4.34M | -17.19% |
| 9/30/2023 | $ 26.52M | $ 0 | 0% |
| 6/30/2023 | $ 27.62M | $ 0 | 0% |
Key Performance Insights, Last 5 Years
- IMPACT BIOMEDICAL INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, IMPACT BIOMEDICAL INC's average ROE has been -213.53%.
- The median ROE for IMPACT BIOMEDICAL INC during this period was -18.28%
- IMPACT BIOMEDICAL INC reached its highest ROE over the past 5 years at 3.7%.
- The lowest ROE recorded by IMPACT BIOMEDICAL INC in the same timeframe -650.98%
IMPACT BIOMEDICAL INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for IMPACT BIOMEDICAL INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 27.62M ]
(=) ROE [ 0% ] IBO - Return on Equity, Last 5 years
-650.98%
Minimum
Mar 31, 2025
3.7%
Maximum
Sep 30, 2024
-213.53%
Average
-18.28%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |